Patients The NHS risk crisis: The failure of risk in a complex health... *Disclaimer: The views and opinions expressed here are the author’s own and do not necessarily reflect those of pharmaphorum or its editorial staff.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.